Skip to main content

Privacy concerns mar Israeli deal with Pfizer

Some Israelis are worried that the agreement with Pfizer prioritizing Israel in its vaccine distribution involves the provision of personal information to the company.
An Israeli health worker administers a dose of the Pfizer-BioNtech Covid-19 vaccine, at the Clalit Health Services installed at the Pais Arena Sport Hall in Jerusalem, on January 21, 2021. (Photo by Emmanuel DUNAND / AFP) (Photo by EMMANUEL DUNAND/AFP via Getty Images)

Israel’s Ministry of Health recently signed an agreement on collecting epidemiological data with coronavirus vaccine maker Pfizer. According to the agreement, Israel will provide statistical information and epidemiological data about the impact of the COVID-19 vaccine on Israelis who received it to allow the company to assess its efficiency. In exchange for this information, Pfizer promised to give Israel preference over other countries in obtaining the vaccine and that it would provide enough vaccines to vaccinate the entire adult population.

There have been complaints about a lack of transparency around the agreement. They were especially concerned about the transfer of medical information pertaining to Israelis who were vaccinated that could allegedly be given to Pfizer without the patients’ consent. People wondered how Pfizer would use this information and if there was any risk that personal information about people receiving the vaccine would be revealed to the company. They asked how the government planned to ensure that privacy would not be violated, particularly when it comes to medical issues.

Access the Middle East news and analysis you can trust

Join our community of Middle East readers to experience all of Al-Monitor, including 24/7 news, analyses, memos, reports and newsletters.

Subscribe

Only $100 per year.